4 views
# Class of cardiovascular diseases # --- [![](https://cardio-balance-ph.store-best.net/img/9.jpg)](https://cardio-balance-ph.store-best.net) <div style="height:500px;"></div> ## NSAIDs in cardiovascular diseases ## My sudden blood pressure diagnosis came at a time when I was too stressed. I was getting frequent headaches but always associated with long hours in front of the screen. Dr. told me to control my blood pressure with medicines, lifestyle changes and diet, or I could get a stroke. My husband bought me Cardio Balance to help me lower down my bp naturally. He was the one who monitored my reading. And to our amazement, it reduced from around 145/115 to 124/82 and stayed there. Honestly, it’s a lifesaver for me. NSAIDs in cardiovascular disease: risks and clinical implications Non-steroidal anti-inflammatory Drugs (NSAIDs) are among the most commonly used drugs worldwide and are mainly used for the treatment of pain, inflammation and fever. Despite their wide distribution and OTC availability (over‑the‑counter) you are associated with a number of side effects, particularly in patients with existing cardiovascular disease (CVD). Pharmacological mechanisms of action and cardiovascular effects The effect of the NSAIDs is based on the inhibition of the Cyclooxygenase enzymes (COX‑1 and COX‑2), for the synthesis of prostaglandins responsible. Prostaglandins play an important role in the Regulation of vascular tone, platelet aggregation and Renal blood flow. The selective or non-selective inhibition of these enzymes can trigger the following cardiovascular effects: Increase in blood pressure through a reduction in vasodilator of prostaglandins and decreased renal function. Fluid retention: due to changes in renal perfusion and increased sodium retention. Thromboembolic events: in particular, in the case of selective COX‑2 inhibitors, which affect platelet function less, but the production of prostacyclin (PGI₂) in the vessel to inhibit walls. Epidemiological Evidence Several large observational studies and meta-analyses have shown that the intake is associated with the NSAIDs with an increased risk for cardiovascular events. In particular: an increased risk for myocardial infarction (MI), a higher incidence of stroke, an increase of congestive heart failure exacerbations, a possible risk for arrhythmic events. The risk seems to be dose and duration of intake and the specific NSAIDs to hang out. For example, it was described for Diclofenac significantly higher cardiovascular risk than for Naproxen. Risk groups Particularly patients with risk: of existing coronary heart disease (CHD), arterial hypertension, Diabetes mellitus, chronic renal failure Congestive heart failure. Also, elderly patients are exposed to due to Comorbidities and altered pharmacokinetics with an increased risk. Clinical Recommendations Before the regulation of NSAIDs, a careful Benefit-risk assessment should be performed, especially in patients with CVD or elevated cardiovascular risk profile. Recommendations include: The lowest effective dose for the shortest possible duration. Waiver of COX‑2‑selective inhibitors in patients with hollow cardiovascular risk. Preference for Naproxen in some cases, because it has a more favourable cardiovascular profile (but with an increased gastrointestinal risk). Regular monitoring of blood pressure, of renal function, and of Edema during therapy. Educating the patients about the symptoms of cardiovascular complications (e.g., chest pain, shortness of breath, sudden swelling). Conclusion NSAIDs can cause in patients with cardiovascular disease to significant cardiovascular side effects. An individual risk assessment in a differentiated Medicines selection and close Monitoring are crucial to ensure the safety of these drugs in clinical practice. Further research is needed to understand the long-term effects of various NSAIDs on the cardiovascular System. People have long used Hawthorne berries for treating high bp, heart issues, and cholesterol levels. A number of Clinical research conclude that it improves cardiovascular function, shortness of breath, and fatigue. In another study, 1200 mg hawthorn extract or placebo was taken by hypertension patients for 16 weeks. Those who were taking hawthorn extract had a significant decrease in blood pressure than the other group taking a placebo. > Ang mga tableta para pababain ang presyon ng dugo ay natural na nakakatulong para mabilis itong bumalik sa normal, pero inirerekomenda rin na baguhin ang pamumuhay. Ang malusog na pagkain, kontrol sa timbang, regular na ehersisyo, at pag-iwas sa paninigarilyo at alak ay magagandang paraan para maiwasan ang mataas na presyon ng dugo. Siguraduhing mas kaunting sodium (hal. asin) at mas maraming potassium (mga saging, spinach, broccoli) ang mapapasok sa katawan. ![](https://cardio-balance-ph.store-best.net/img/go2.png) <a href="https://pad.yuka.dev/s/QVJf5VXH4A">Presyong pang-promosyon</a> Ginagamit ito bilang biologically active na pampadagdag sa pagkain - dagdag na pinagmumulan ng mga bitamina - B2, B6, C, mga organikong asido - mansanas, succinic, glutamine. Mga sangkap: malic acid, succinic acid, glutamic acid, badan extract, ascorbic acid, bitamina B2, B6. <a href="https://pad.gusted.xyz/s/d2bU9VUCX">Class of cardiovascular diseases</a> Heart and circulation: your path to a better quality of life You worry about your heart and circulatory system? Any cardiovascular disease is a serious challenge — but you don't have to be alone in this. Our Team of specialists from cardiologist and internist Doctors offers comprehensive care for all diseases of the circulatory system: coronary heart disease; Heart rhythm disorders; High blood pressure; Congestive heart failure; Vascular diseases. Why do we need to be treated? Precise diagnosis: We use the latest techniques of ECG and Holter via ultrasound examinations to stress tests. Individual treatment plan: Every Patient is unique. Therefore, we develop a tailor-made therapy. Prevention instead of reaction: Learn how to lower your risk for cardiovascular diseases in a sustainable way. Close follow up: We will accompany you throughout the duration of therapy and beyond. Our goal: your heart should beat in the rhythm — so you can feel more energy and joy of life. Appointment: Call us now at: +49 XXX XXXXXXX or write an E‑Mail to info@beispiel-klinik.de. You can rely on Expertise, trust and human proximity. Your heart will thank you! Clinic for cardiovascular diseases Your health is our passion. ## Tablets of hypertension moxonidine ## Blood pressure tablets: Moxonidine as a modern antihypertensives preparation High blood pressure (arterial hypertension) is one of the most common chronic diseases in the world and is regarded as a major risk factor for cardiovascular events such as heart attack and stroke. The pharmacotherapy aims to keep the blood pressure in the long term, control and to reduce the complication rate. An important Option in this context, tablets with the drug Moxonidine are. Pharmacological Properties Moxonidine belongs to the group of centrally acting anti-hypertensive agents. It selectively acts as an Agonist at the imidazoline receptors in the Central nervous system (especially in the Nucleus tractus solitarii), which leads to a decrease in the sympathetic activity. In contrast to other centrally-acting substances Moxonidine has to α₂ a lower affinity‑Adrenoceptors, which are typical side effects such as sedation and dry mouth significantly reduced. Mechanism of action Through the Stimulation of the imidazoline receptors in the peripheral sympathetic muscle tone regulation is reduced. This leads to the following effects: Vasodilatation (enlargement of blood vessels), Reduction of peripheral vascular resistance, Reduction of heart rate and cardiac output, Removal of the Renin‑Angiotensin‑aldosterone activity. The resulting reduction in systolic and diastolic blood pressure occurs within 30-60 minutes after oral administration, with a Maximum after 2-3 hours. The duration of action is 12 hours, which allows for twice daily use (morning and evening). Clinical application and dosage Moxonidine is used in the treatment of mild-to-moderate arterial hypertension, particularly in patients with metabolic syndrome or insulin resistance, since it has no negative influence on glucose and Lipid metabolism, and even a certain amount of insulin‑sensitizing effect. The standard dosage starts at 0.2 mg per day, may be increased after 2-4 weeks, if necessary, to 0.4 mg up to a maximum of 0.6 mg daily. The tablets should be swallowed whole with a little water, preferably at the same time of the day. Side effects and contraindications Among the possible side effects: Headache, Dizziness, Fatigue, slight bradycardia, Dryness of the mouth (rarely). Contraindicated Moxonidine is: severe bradycardia or AV‑Block II and III degree, acute heart failure, severe hepatic or renal insufficiency, known Hypersensitivity to the active substance. Conclusion Tablets with Moxonidine is an effective and well-tolerated Option for long-term therapy of hypertension. Their favorable side-effect profile and the positive metabolic effects, particularly for special groups of patients, attractive. Individual dosage and regular blood pressure control, however, are essential to the optimal therapy to adjust and minimize potential risks. <a href="https://notas.laotra.red/s/9QddNbJtVe">Class of cardiovascular diseases</a> Class of cardiovascular diseases. <a href="https://hedgedoc.ichmann.de/s/7SoP6O4ZE6">NSAIDs in cardiovascular diseases</a> <a href="https://md.mandragot.org/s/lB6b-iAmzw">Tablets of hypertension moxonidine</a> <a href="https://md.gafert.org/s/aGy-A-qH6">Cardiovascular diseases are the first</a> <a href="https://pad.aleph.world/s/M6CUgl_1o">https://pad.aleph.world/s/M6CUgl_1o</a> <a href="https://md.nolog.cz/s/mONcNhEN8">https://md.nolog.cz/s/mONcNhEN8</a> <a href="https://pad.medialepfade.net/s/rFkXO0G6d">https://pad.medialepfade.net/s/rFkXO0G6d</a> <a href="https://md.mandragot.org/s/shvcAWGKu9">https://md.mandragot.org/s/shvcAWGKu9</a> <a href="https://pad.demokratie-dialog.de/s/0yffqYrjH0">https://pad.demokratie-dialog.de/s/0yffqYrjH0</a> <a href="https://hack.utopia-lab.org/s/axBLatA9J">https://hack.utopia-lab.org/s/axBLatA9J</a> <a href="https://md.interhacker.space/s/aSqJLT_YG">https://md.interhacker.space/s/aSqJLT_YG</a> <a href="https://hedgedoc.et.aksw.org/s/xZ0H7RLXV">https://hedgedoc.et.aksw.org/s/xZ0H7RLXV</a> <a href="https://pads.dgnum.eu/s/ZdDC22-a6P">https://pads.dgnum.eu/s/ZdDC22-a6P</a> <a href="https://doc.interscalar.eu/s/9Hjw3jlcD">https://doc.interscalar.eu/s/9Hjw3jlcD</a> <a href="https://pad.nantes.cloud/s/eRPkyHbD3j">https://pad.nantes.cloud/s/eRPkyHbD3j</a> <a href="https://md.softwarefreedom.net/s/keWxx5Wkl">https://md.softwarefreedom.net/s/keWxx5Wkl</a> <a href="https://hdoc.csirt-tooling.org/s/1bMhLtusWY">https://hdoc.csirt-tooling.org/s/1bMhLtusWY</a> <a href="https://doc.neutrinet.be/s/yDbO4UJAwn">https://doc.neutrinet.be/s/yDbO4UJAwn</a> <a href="https://md.globenet.org/s/oh9PnZotU">https://md.globenet.org/s/oh9PnZotU</a> <a href="https://omoffice.de/s/SyX8EpdMfx">https://omoffice.de/s/SyX8EpdMfx</a> <a href="https://md.giplt.nl/s/2_NyYxG3OQ">https://md.giplt.nl/s/2_NyYxG3OQ</a> <a href="https://hedgedoc.team23.org/s/7ztswI1Z0Z">https://hedgedoc.team23.org/s/7ztswI1Z0Z</a> <a href="https://hedgedoc.obermui.de/s/RNVC653-5Z">https://hedgedoc.obermui.de/s/RNVC653-5Z</a> <a href="https://notas.gaiacoop.tech/s/taNGhFhig">https://notas.gaiacoop.tech/s/taNGhFhig</a> <a href="https://pad.n39.eu/s/dY-h7uk_Xz">https://pad.n39.eu/s/dY-h7uk_Xz</a> <a href="https://doc.hkispace.com/s/IO3THnAJH">https://doc.hkispace.com/s/IO3THnAJH</a> <a href="https://pad.ccc-p.org/s/aaDbnP65G6">https://pad.ccc-p.org/s/aaDbnP65G6</a> <a href="https://pad.gusted.xyz/s/MznUKS13v">https://pad.gusted.xyz/s/MznUKS13v</a> <a href="https://hedgedoc.nrp-nautilus.io/s/2zX7QJHNa9">https://hedgedoc.nrp-nautilus.io/s/2zX7QJHNa9</a> <a href="https://notes.simeonreusch.com/s/I8Za1Hn-r">https://notes.simeonreusch.com/s/I8Za1Hn-r</a> <a href="https://md.cortext.net/s/VEKC2dIvJ">https://md.cortext.net/s/VEKC2dIvJ</a> <a href="https://pads.cantorgymnasium.de/s/iLIdhJyVa">https://pads.cantorgymnasium.de/s/iLIdhJyVa</a> <a href="https://hd.wedler.me/s/6Xh9Qxw9K">https://hd.wedler.me/s/6Xh9Qxw9K</a> <a href="https://md.eris.cc/s/n5kQc7kR41">https://md.eris.cc/s/n5kQc7kR41</a> <a href="https://write.frame.gargantext.org/s/rk1SzpuGfg">https://write.frame.gargantext.org/s/rk1SzpuGfg</a> <a href="https://doc.gnuragist.es/s/7hKJU6fsDj">https://doc.gnuragist.es/s/7hKJU6fsDj</a> <a href="https://pad.aleph.world/s/CR4SGCbaa">https://pad.aleph.world/s/CR4SGCbaa</a> <a href="https://pad.hxx.cz/s/O00wr6sDUj">https://pad.hxx.cz/s/O00wr6sDUj</a> <a href="https://hedge.grin.hu/s/1gkd66ROoK">https://hedge.grin.hu/s/1gkd66ROoK</a> <a href="https://md.infs.ch/s/F4jf9Tn-WJ">https://md.infs.ch/s/F4jf9Tn-WJ</a> <a href="https://md.micronited.de/s/SkbiE6uffl">https://md.micronited.de/s/SkbiE6uffl</a> <a href="https://doc.cisti.org/s/g7Ii21N72E">https://doc.cisti.org/s/g7Ii21N72E</a> <a href="https://codi.sevenvm.de/s/a58ezYwH9">https://codi.sevenvm.de/s/a58ezYwH9</a> <a href="https://hedgedoc.private.coffee/s/HWKj0gt--">https://hedgedoc.private.coffee/s/HWKj0gt--</a> <a href="https://dok.kompot.si/s/F0t416S08l">https://dok.kompot.si/s/F0t416S08l</a> <a href="https://hedge.amosamos.net/s/hr7UGdaz2u">https://hedge.amosamos.net/s/hr7UGdaz2u</a> <a href="https://hedgedoc.jcg.re/s/pqerUFCVMk">https://hedgedoc.jcg.re/s/pqerUFCVMk</a> <a href="https://doc.fung.uy/s/XXKKcZIank">https://doc.fung.uy/s/XXKKcZIank</a> <a href="https://pad.fablab-siegen.de/s/reR8G-5-mw">https://pad.fablab-siegen.de/s/reR8G-5-mw</a> <a href="https://pad.yuka.dev/s/RURqtV4Jk3">https://pad.yuka.dev/s/RURqtV4Jk3</a> <a href="https://n.jo-so.de/s/7npdb6e7e">https://n.jo-so.de/s/7npdb6e7e</a> <a href="https://pad.mytga.de/s/aEr-c3Eqx">https://pad.mytga.de/s/aEr-c3Eqx</a> <a href="https://pad.medialepfade.net/s/mXbewcek1">https://pad.medialepfade.net/s/mXbewcek1</a> <a href="https://hackmd.k15.synology.me/s/qL6KZrqi5">https://hackmd.k15.synology.me/s/qL6KZrqi5</a> <a href="https://doc.interscalar.eu/s/0zhyYPrGq">https://doc.interscalar.eu/s/0zhyYPrGq</a> <a href="https://pads.tobast.fr/s/cAvrPjyEHX">https://pads.tobast.fr/s/cAvrPjyEHX</a> <a href="https://hedgedoc.digilol.net/s/zhACCVQ2tN">https://hedgedoc.digilol.net/s/zhACCVQ2tN</a> <a href="https://md.sigma2.no/s/3n8L3zdss">https://md.sigma2.no/s/3n8L3zdss</a> <a href="https://md.sebastians.dev/s/8a7Mv2178">https://md.sebastians.dev/s/8a7Mv2178</a> <a href="https://md.coredump.ch/s/b43E6JYH4">https://md.coredump.ch/s/b43E6JYH4</a> <a href="https://om-office.de/s/rkwA4puGMe">https://om-office.de/s/rkwA4puGMe</a> <a href="https://notes.rabjerg.de/s/rJOREpOzGx">https://notes.rabjerg.de/s/rJOREpOzGx</a> <a href="https://doc.hkispace.com/s/DVkVV9lMs">https://doc.hkispace.com/s/DVkVV9lMs</a> <a href="https://www.notizen.kita.bayern/s/_o_rZojFe6">https://www.notizen.kita.bayern/s/_o_rZojFe6</a> <a href="https://hedgedoc.auro.re/s/1L9hCdmtRQ">https://hedgedoc.auro.re/s/1L9hCdmtRQ</a> <a href="https://edit.leiden.digital/s/IwrjnQ-3bV">https://edit.leiden.digital/s/IwrjnQ-3bV</a> <a href="https://pad.koeln.ccc.de/s/gKxk3RCYm">https://pad.koeln.ccc.de/s/gKxk3RCYm</a> <a href="https://notas.laotra.red/s/eIwHK0MyzH">https://notas.laotra.red/s/eIwHK0MyzH</a> <a href="https://hedgedoc.inqbus.de/s/fCZlGGMZq">https://hedgedoc.inqbus.de/s/fCZlGGMZq</a> <a href="https://pad.sra.uni-hannover.de/s/fNxvVdhqb-">https://pad.sra.uni-hannover.de/s/fNxvVdhqb-</a> <a href="https://hedgedoc.ichmann.de/s/oP5unrz29V">https://hedgedoc.ichmann.de/s/oP5unrz29V</a> <a href="https://hedgedoc.et.aksw.org/s/IHtSRVuRx">https://hedgedoc.et.aksw.org/s/IHtSRVuRx</a> <a href="https://notes.llgoewer.de/s/LqH_nzkzE">https://notes.llgoewer.de/s/LqH_nzkzE</a> <a href="https://docs.localcharts.org/s/-u_AMHC27">https://docs.localcharts.org/s/-u_AMHC27</a> <a href="https://docs.snowdrift.coop/s/6TaiEHrRo">https://docs.snowdrift.coop/s/6TaiEHrRo</a> <a href="https://pad.dominick-leppich.de/s/4INigZdKL">https://pad.dominick-leppich.de/s/4INigZdKL</a> <a href="https://hedgedoc.private.coffee/s/R85Wm2LHo">https://hedgedoc.private.coffee/s/R85Wm2LHo</a> <a href="https://pad.mytga.de/s/dE9H5QH73">https://pad.mytga.de/s/dE9H5QH73</a> <a href="https://md.gafert.org/s/dd_ATEmP7">https://md.gafert.org/s/dd_ATEmP7</a> <a href="https://hedgedoc.ffmuc.net/s/unlJM62bLl">https://hedgedoc.ffmuc.net/s/unlJM62bLl</a> <a href="https://pad.multiplace.org/s/By-WSpufze">https://pad.multiplace.org/s/By-WSpufze</a> <a href="https://hedgedoc.stanleysolutionsnw.com/s/TBP0eXzNXK">https://hedgedoc.stanleysolutionsnw.com/s/TBP0eXzNXK</a> <a href="https://pad.cttue.de/s/7H04idxR4">https://pad.cttue.de/s/7H04idxR4</a> <a href="https://doc.neutrinet.be/s/3szv6od3bO">https://doc.neutrinet.be/s/3szv6od3bO</a> <a href="https://hdoc.csirt-tooling.org/s/l6zHZds2EA">https://hdoc.csirt-tooling.org/s/l6zHZds2EA</a> <a href="https://doc.spiegie.de/s/HJM5UCXwI">https://doc.spiegie.de/s/HJM5UCXwI</a> <a href="https://hackmd.openmole.org/s/BzZ4ALTDD">https://hackmd.openmole.org/s/BzZ4ALTDD</a> <a href="https://md.coredump.ch/s/-n5tL5FjP">https://md.coredump.ch/s/-n5tL5FjP</a> ## Cardiovascular diseases are the first ## Cardiovascular diseases: The silent threat no. 1 Cardiovascular diseases are the leading causes of death and Germany is no exception. According to statistics from the Robert Koch Institute, hundreds of thousands die annually from the consequences of heart attacks, strokes and other diseases of the cardiovascular system. These diseases are not only an individual tragedy, but also a great burden for the health system and society as a whole. What exactly counts actually, the cardiovascular diseases? These include: Coronary heart disease (narrowing of the heart arteries); Heart attack (due to sudden closure of a blood vessel); Stroke (due to interruption of the blood flow in the brain); High blood pressure (arterial hypertension); Heart failure (the heart is not pumping enough blood); various heart rhythm disorders. Why these diseases are so dangerous? A big Problem is that many of the risk factors stand out for a long time hardly, or not at all. High blood pressure, elevated blood fats, or high blood sugar can remain for many years unnoticed and in the meantime, damage to the blood vessels do. That's why they call cardiovascular diseases often silent Killer. What are the factors that increase the risk? There are risk factors that you can't affect: the age (with age increases the risk); gender (men earlier, and more frequently affected); a hereditary predisposition. However, many other risk factors are in our own hands: Lack of exercise; unhealthy diets (excessive salt, fat, sugar); Overweight and obesity; Smoking (increases the risk for a heart attack dramatically); excessive consumption of alcohol; Duration of the stress. Prevention: The best medicine The good news is that Through a healthy lifestyle, the risk can be significantly reduced. Simple measures can make a big difference: regular physical activity (at least 150 minutes of moderate exercise per week); a balanced diet with lots of fruits, vegetables, and fiber; Waiver of Smoking; moderate use of alcohol; regular health checks (blood pressure, blood fats and blood sugar control). Conclusion Cardiovascular diseases need not be destiny. By our way of life, rethink and preventive examinations, we can protect our heart and our blood vessels. Health begins in the everyday life — and every step in the direction of movement and a balanced diet that counts. You invest in your heart: It is working for you every day — give him the best care possible!